A. Hamdan

发表

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

D. Neuberg, D. Kufe, D. DeAngelo, 2016, Science Translational Medicine.

Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.

Ang Li, Walter H Dzik, Shelley Hurwitz, 2017, The Lancet. Haematology.

Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency

R. Kaufman, L. Uhl, P. Bendapudi, 2017, Transfusion.

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma

A. Kruisbeek, J. Rosenblatt, D. Avigan, 2017, Journal of immunotherapy.

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

R. Soiffer, R. Joyce, Shuli Li, 2016, Blood.

Adjuvant low-dose rituximab and plasma exchange for acquired TTP.

J. Zwicker, J. Sadler, J. Muia, 2019, Blood.

Successful Treatment of Refractory Guillain-Barré Syndrome with Alemtuzumab in a Patient with Chronic Lymphocytic Leukemia

E. Uhlmann, R. Joyce, D. Tzachanis, 2014, Acta Haematologica.

Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation

Emily B Hanhauser, A. LaCasce, D. Kuritzkes, 2018, PloS one.

Pure Red Cell Aplasia after ABO-Mismatched Allogeneic Stem Cell Transplantation Treated with Therapeutic Plasma Exchange and Rituximab

E. Uhlmann, R. Joyce, J. Rosenblatt, 2015 .

New insights into the pathogenesis and therapy of Behçet's disease.

T. Arayssi, A. Hamdan, 2004, Current opinion in pharmacology.

Human immunodeficiency virus-associated lung carcinoma presenting as cutaneous metastases.

L. Pantanowitz, B. Dezube, A. Hamdan, 2009, Clinical lung cancer.

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy

Emily B Hanhauser, A. LaCasce, D. Kuritzkes, 2017, The Journal of infectious diseases.

Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison

T. Arayssi, I. Uthman, A. F. Masri, 2006, Clinical Rheumatology.

Cross-cultural adaptation and validation of Behçet's disease quality of life questionnaire

A. Sibai, T. Arayssi, I. Uthman, 2011, BMC medical research methodology.

TNF polymorphisms in patients with Behçet disease: a meta-analysis.

C. Farra, T. Arayssi, I. Uthman, 2010, Archives of medical research.

Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative

Ang Li, Richard Kaufman, C. Stowell, 2015, British journal of haematology.

CTLA-4 gene variants are not associated with Behçet's disease or its clinical manifestations.

P. Zalloua, T. Arayssi, N. Makhoul, 2008, Clinical and Experimental Rheumatology.

Derivation and Prospective Validation of a Predictive Score for the Rapid Diagnosis of Thrombotic Thrombocytopenic Purpura: The Plasmic Score

C. Stowell, M. Marques, R. Kaufman, 2014 .

TNF polymorphisms in Lebanese patients with Behçet's disease.

C. Farra, T. Arayssi, I. Uthman, 2008, Clinical and experimental rheumatology.